Skip to main content

Table 5 Changes from baseline in hematological parameters in the saffron and placebo groups

From: The effects of saffron supplementation on inflammation and hematological parameters in patients with sepsis: a randomized controlled trial

Variables

Group

Before intervention

After intervention

P-value**

Mean changes#

p-value

WBC (µL)

Saffron

13731.06 ± 3718.4

9554.71 ± 2961.91

<0.001

-4176.34 ± 4063.01

<0.001

Placebo

13499.43 ± 4790.74

13,561 ± 3316.32

0.92

61.57 ± 4118.97

P-value

0.79

<0.001

  

Cohen’s d effect size (95% CI)

0.05 (-0.36, 0.47)

-1.27 (-1.69, -0.86)

  

Neutrophils (%)

Saffron

74.31 ± 9.59

71.83 ± 15.22

0.34

-2.47 ± 17.37

0.48

Placebo

77.07 ± 8.43

74.13 ± 7.84

0.05

-2.93 ± 9.95

P-value

0.15

0.37

  

Cohen’s d effect size (95% CI)

-0.31 (-0.72, 0.11)

-0.19 (-0.61, 0.23)

  

Lymphocyte (%)

Saffron

17.19 ± 7.52

17.58.5.37

0.60

0.39 ± 5.09

0.21

Placebo

14.61 ± 5.82

15.33 ± 5

0.46

0.71 ± 6.46

P-value

0.07

0.04

  

Cohen’s d effect size (95% CI)

0.38 (-0.04, 0.8)

0.43 (0.01, 0.85)

  

RBC (µL)

Saffron

3.83 ± 0.61

3.75 ± 0.45

0.32

-0.080.54

0.18

Placebo

3.58 ± 0.34

3.54 ± 0.35

0.49

-0.03 ± 0.36

P-value

0.02

0.02

  

Cohen’s d effect size (95% CI)

0.51 (0.09, 0.93)

0.52 (0.1, 0.94)

  

Hb (g/dL)

Saffron

10.36 ± 1.49

10.24.1.58

0.62

-0.11 ± 1.55

0.19

Placebo

10.16 ± 1.42

9.81 ± 1.18

0.10

-0.34 ± 1.38

P-value

0.50

0.14

  

Cohen’s d effect size (95% CI)

0.14 (-0.28, 0.56)

0.31 (-0.11, 0.73)

  

Hct (%)

Saffron

31.44 ± 4.93

32.05 ± 4.87

0.37

0.60 ± 4.54

0.06

Placebo

30.79 ± 4.57

30.39 ± 2.66

0.56

-0.39 ± 4.55

P-value

0.51

0.04

  

Cohen’s d effect size (95% CI)

0.14 (-0.28, 0.56)

0.42 (0.00, 0.84)

  

MCV (fl.)

Saffron

84.48 ± 6.47

85.15 ± 5.74

0.25

0.66 ± 3.84

0.58

Placebo

85.06 ± 5.30

85.90 ± 4.39

0.10

0.84 ± 3.44

P-value

0.64

0.48

  

Cohen’s d effect size (95% CI)

-0.1 (-0.52, 0.32)

-0.15 (-0.57, 0.27)

  

MCH (pg)

Saffron

27.10 ± 2.65

26.97 ± 1.97

0.54

-0.12 ± 1.43

0.54

Placebo

27.01 ± 1.77

27.03 ± 1.65

0.86

0.02 ± 0.90

P-value

0.86

0.18

  

Cohen’s d effect size (95% CI)

0.04 (-0.38, 0.46)

-0.03 (-0.45, 0.39)

  

MCHC (g/dl)

Saffron

32.10 ± 1.81

31.66 ± 1.15

0.06

-0.43 ± 1.55

0.28

Placebo

31.67 ± 1.14

31.80 ± 1.42

0.60

0.12 ± 1.60

P-value

0.18

0.61

  

Cohen’s d effect size (95% CI)

0.28 (-0.13, 0.70)

-0.11 (-0.53, 0.31)

  

PLT (µL)

Saffron

278990.79 ± 130107.67

308031.36 ± 78889.79

0.11

29040.56 ± 120466.12

0.2

Placebo

243621.4 ± 112479.34

318532.10 ± 108062.43

<0.001

74910.70 ± 108276.04

P-value

0.17

0.60

  

Cohen’s d effect size (95% CI)

0.29 (-0.13, 0.71)

-0.11 (-0.53, 0.31)

  
  1. Abbreviations: WBC; white blood cell count, RBC; red blood cell, PLT; Platelet, Hb, hemoglobin; Hct, Hematocrit, CI: confidence interval
  2. Data are shown as means ± standard deviation
  3. *P-values were obtained from independent sample t-test, **paired-sample t-test, and #analysis of covariance (ANCOVA) with the adjustment for baseline values